Navigation Links
Quest for genes involved in celiac disease
Date:4/5/2011

This release is available in Spanish.

Celiac disease (CD) involves intolerance to gluten and, consequently, suffering chronic illness in the small intestine. It is a genetic disorder, the immunological indications of which can be traced in the human body prior to the everyday activities of future sufferers being affected. For example, persons with genetic antecedents for CD develop antibodies against the gene tTG (the enzyme known as tissue transglutaminase), even before the illness becomes active, due to a cell reaction against gluten.

The clinical symptoms of CD appear only in the final stages of the disease. This is why it is important to find the genes linked to it, thus facilitating an early diagnosis, as well as fighting against CD before it becomes an active illness. In effect, biologist Ms Ainara Castellanos has opened a door to the elucidation of this: her research was aimed at identifying genes that may have a functional involvement in the CD, developing a tool which, amongst other things, looked at the changes in gene expression. For example, she was able to verify that the gene known as UBD may be linked to CD. Her thesis, defended at the University of the Basque Country (UPV-EHU), is entitled, Functional players in celiac disease: identification and genetic association.

Intestinal biopsies at Cruces hospital

In order to undertake her research, Ms Castellanos used intestinal biopsies at the Hospital de Cruces (in Barakaldo, near the Basque city of Bilbao), drawing up a strategy that crossed data on gene levels of expression gathered from these biopsies, information about the anatomical regions closely linked to CD, and various bioinformatic instruments.

The research undertaken in this thesis confirmed that this tool, which takes levels of expression of the genes into account, is useful in identifying those which are especially susceptible to CD. In fact, thanks to the work, Ms Castellanos was able to distinguish, in the anatomical regions closely linked to CD, a number of genes subjected to alterations in their expression caused by gliadine (a protein that forms part of gluten), and she verified that these genes are candidates for being functionally involved with CD.

Besides this, based on information obtained from intestinal biopsies of the celiac patients, she was able to undertake an analysis and a general description of the alterations in expression caused by gliadine in the intestinal mucous. Given all this, Ms Castellanos concluded that, in those cases in which there is CD, malfunctions in intercellular communication, in intracellular signalling, in ubiquitine proteins and in a number of other networks are produced. Thus, she confirmed that CD is a complex and multifactorial illness. Moreover, on describing the changes happening with the levels of expression, she has provided guidelines on understanding how CD develops and found new factors which influence this progress of the disease.

Ubiquitine D

Amongst the networks mentioned previously, Ms Castellanos stressed the ubiquitine proteins, concretely ubiquitine D (UBD). An over-expression of UBD in the intestinal biopsies of the celiac patients and, in relation to this, a genetic variant or polymorphism linked to CD. As she explains in her thesis, this polymorphism could precisely be the inductor of this over-expression. Ms Castellanos stressed that the same could happen with other genes, candidates for being involved in CD. As a consequence, the example of UBD has confirmed that the observation of the genetic expressions can help in finding those genes which, while being unknown as yet, are linked to the onset of CD.


'/>"/>

Contact: Amaia Portugal
a.portugal@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
Source:Eurekalert

Related biology news :

1. U of A researcher questions whether genius might be a result of hormonal influences
2. UofL biostatistician to develop statistical model that could help answer medical questions
3. Experts question aspects of prescribed burning
4. Ancient teeth raise new questions about the origins of modern man
5. The quest for the ultimate blue cheese
6. New Anglo-Swiss research questions impact of GM wheat on insects
7. What is life? New answers to an age-old question in astrobiology
8. New UCLA study raises questions about genetic testing of newborns
9. To be or not to be endangered? Listing of rare Hawaiian coral species called into question
10. Scientists question fisheries health test
11. Scientists question indicator of fisheries health, evidence for fishing down food webs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/15/2016)... April 15, 2016 Research ... Gait Biometrics Market 2016-2020,"  report to their offering.  ... ) , ,The global gait biometrics market is ... during the period 2016-2020. Gait analysis ... can be used to compute factors that are ...
(Date:3/29/2016)... RATON, Florida , March 29, 2016 ... or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are ... DNA in ink used in a variety of writing ... theft. Buyers of originally created collectibles from athletes on ... through forensic analysis of the DNA. ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , June 27, 2016   Ginkgo Bioworks ... to industrial engineering, was today awarded as one ... selection of the world,s most innovative companies. Ginkgo ... scale for the real world in the nutrition, ... engineers work directly with customers including Fortune 500 ...
(Date:6/24/2016)... ... , ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical ... mesothelioma. Their findings are the subject of a new article on the Surviving Mesothelioma ... in the blood, lung fluid or tissue of mesothelioma patients that can help point ...
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) ... precise treatments and faster cures for prostate cancer. Members of the Class of ... 15 countries. Read More About the Class of 2016 ... ... ...
Breaking Biology Technology: